Tolerance in clinical liver transplantation: The long road ahead
Jean C. Emond, Adam D. Griesemer – 7 October 2016
Jean C. Emond, Adam D. Griesemer – 7 October 2016
Fen Huang, Yunlong Li, Wenhai Yu, Chenchen Yang – 7 October 2016
Christine Baechlein, Paul Becher – 7 October 2016
The evidence to support therapeutic decisions in patients with cirrhosis and fundal and ectopic varices is scarce, and treatment is controversial. In addition, since these varices are infrequent, clinicians have limited experience and knowledge of the therapeutic options.
Maja Thiele, Bjørn Stæhr Madsen, Aleksander Krag – 6 October 2016
Luis Ibáñez‐Samaniego, Magdalena Salcedo, Javier Vaquero, Rafael Bañares – 6 October 2016 – De novo autoimmune hepatitis (DAIH) is a rare clinical condition with features that resemble those of autoimmune hepatitis (AIH) in patients undergoing liver transplantation (LT) for nonautoimmune liver disease. The diagnosis of this entity has been based on the presence of biochemical and histological patterns similar to those observed in the primary AIH, although several considerations must be taken into account.
Andrea Lauterio, Stefano Di Sandro, Salvatore Gruttadauria, Marco Spada, Fabrizio Di Benedetto, Umberto Baccarani, Enrico Regalia, Ernesto Melada, Alessandro Giacomoni, Matteo Cescon, Davide Cintorino, Giorgio Ercolani, Matteo Rota, Giorgio Rossi, Vincenzo Mazzaferro, Andrea Risaliti, Antonio Daniele Pinna, Bruno Gridelli, Luciano De Carlis – 6 October 2016 – Major concerns about donor morbidity and mortality still limit the use of living donor liver transplantation (LDLT) to overcome the organ shortage.
Antonio Solinas, Diego F. Calvisi – 6 October 2016
Dimitri Tchernitchko, Virginie Scotet, Thibaud Lefebvre, Carine L'Hostis, Isabelle Gourlaouen, Marie‐Christine Merour, Khadidja Rebah, Katell Peoc'h, Suzanne Assari, Claude Ferec, Hervé Puy, Gérald Le Gac – 6 October 2016
Robert J. Fontana, Ronald E. Engle, Robert H. Purcell, William M. Lee, On behalf of the ALFSG – 6 October 2016